PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Aralen (Chloroquine)- FDA 19 Drug Disease Infection 766,637 2 0.00 -0.95 0.11 0.55
Aralen (Chloroquine)- FDA 19 Drug Disease Stroke 146,992 1 0.00 -0.97 0.05 0.57
Aralen (Chloroquine)- FDA 19 Drug Disease Shock 134,031 2 0.00 -0.95 0.11 0.58
Aralen (Chloroquine)- FDA 19 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.03 -0.97 0.05 0.79
Aralen (Chloroquine)- FDA 19 Drug Disease Arthritis 128,324 3 0.00 -0.92 0.16 0.59
Aralen (Chloroquine)- FDA 19 Drug Drug Acitretin (Soriatane)- FDA 13 2 0.13 -0.87 0.15 0.88
Aralen (Chloroquine)- FDA 19 Drug Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Aralen (Chloroquine)- FDA 19 Drug Disease Malaria 56,215 7 0.01 -0.79 0.37 0.63
Aralen (Chloroquine)- FDA 19 Drug Drug Atovaquone (Mepron)- FDA 11 3 0.21 -0.78 0.27 0.90
Aralen (Chloroquine)- FDA 19 Drug Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Aralen (Chloroquine)- FDA 19 Drug Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
Aralen (Chloroquine)- FDA 19 Drug Drug Doxycycline 9,324 2 0.00 -0.95 0.11 0.65
Mu-Type Opioid Receptor 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Target CD146 729 1 0.01 -0.97 0.05 0.70
ALK Phos 19 Target Disease Cholesterol 182,390 3 0.00 -0.92 0.16 0.58
ALK Phos 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
ALK Phos 19 Target Disease Hepatitis 163,842 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
ALK Phos 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Skin Rash 3,684 1 0.00 -0.97 0.05 0.65
ALK Phos 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.05 0.59
Amitiza (Lubiprostone)- FDA 19 Drug Disease Constipation 15,810 16 0.03 -0.40 0.84 0.69
Amitiza (Lubiprostone)- FDA 19 Drug Disease Ileus 9,091 1 0.00 -0.97 0.05 0.63
Amitiza (Lubiprostone)- FDA 19 Drug Disease Irritable Bowel Syndrome 8,230 14 0.04 -0.51 0.74 0.71
Amitiza (Lubiprostone)- FDA 19 Drug Disease Pain 409,851 5 0.00 -0.86 0.26 0.58
Amitiza (Lubiprostone)- FDA 19 Drug Drug Alosetron Hydrochloride (Lotronex)- FDA 27 2 0.09 -0.91 0.11 0.86
Amitiza (Lubiprostone)- FDA 19 Drug Drug Alprostadil (Prostin VR Pediatric)- FDA 26 14 0.63 -0.35 0.74 0.96
Eotaxin-2/CCL24 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Eotaxin-2/CCL24 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Eotaxin-2/CCL24 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
Eotaxin-2/CCL24 19 Target Disease Psoriasis 26,882 1 0.00 -0.97 0.05 0.60
Eotaxin-2/CCL24 19 Target Disease Asthma 109,610 4 0.00 -0.89 0.21 0.60
Eotaxin-2/CCL24 19 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.05 0.65
Eotaxin-2/CCL24 19 Target Target CCL8 197 1 0.02 -0.97 0.05 0.75
Eotaxin-2/CCL24 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
Eotaxin-2/CCL24 19 Target Target CCL1 220 1 0.02 -0.97 0.05 0.74
Kallikrein-8 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Kallikrein-8 19 Target Disease Psoriasis 26,882 2 0.00 -0.95 0.11 0.62
Kallikrein-8 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Kallikrein-8 19 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.11 0.58
Kallikrein-8 19 Target Disease Lung Cancer 91,416 1 0.00 -0.97 0.05 0.58
Kallikrein-8 19 Target Disease Inflammation 252,734 2 0.00 -0.95 0.11 0.57
Kallikrein-8 19 Target Disease Glioblastoma 17,933 1 0.00 -0.97 0.05 0.61
Tegument Protein Vp16 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54